These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 92624)

  • 1. Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome.
    Maiztegui JI; Fernandez NJ; de Damilano AJ
    Lancet; 1979 Dec; 2(8154):1216-7. PubMed ID: 92624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral treatment of Argentine hemorrhagic fever.
    Enria DA; Maiztegui JI
    Antiviral Res; 1994 Jan; 23(1):23-31. PubMed ID: 8141590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of dose of neutralising antibodies in treatment of Argentine haemorrhagic fever with immune plasma.
    Enria DA; Briggiler AM; Fernandez NJ; Levis SC; Maiztegui JI
    Lancet; 1984 Aug; 2(8397):255-6. PubMed ID: 6146809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of Argentine hemorrhagic fever with convalescent's plasma. 4433 cases].
    Ruggiero HA; Pérez Isquierdo F; Milani HA; Barri A; Val A; Maglio F; Astarloa L; Gonzalez Cambaceres C; Milani HL; Tallone JC
    Presse Med; 1986 Dec; 15(45):2239-42. PubMed ID: 2949253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduction in the mortality of American hemorrhagic fever (AHF) during treatment with immune serums].
    Maiztegui JI; Fernández NJ; de Damilano AJ
    Medicina (B Aires); 1978; 38(6 Pt 1):743. PubMed ID: 750869
    [No Abstract]   [Full Text] [Related]  

  • 6. [Late neurologic syndrome in patients with Argentinian hemorrhagic fever treated with immune plasma].
    Enria DA; de Damilano AJ; Briggiler AM; Ambrosio AM; Fernández NJ; Feuillade MR; Maiztegui JI
    Medicina (B Aires); 1985; 45(6):615-20. PubMed ID: 3023790
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of junin virus-infected guinea pigs with immune serum: development of late neurological disease.
    Kenyon RH; Green DE; Eddy GA; Peters CJ
    J Med Virol; 1986 Nov; 20(3):207-18. PubMed ID: 3023540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous interferon in Argentine hemorrhagic fever.
    Levis SC; Saavedra MC; Ceccoli C; Falcoff E; Feuillade MR; Enria DA; Maiztegui JI; Falcoff R
    J Infect Dis; 1984 Mar; 149(3):428-33. PubMed ID: 6232326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of the treatment of Argentine Hemorrhagic Fever.
    Enría D; Franco SG; Ambrosio A; Vallejos D; Levis S; Maiztegui J
    Med Microbiol Immunol; 1986; 175(2-3):173-6. PubMed ID: 3014290
    [No Abstract]   [Full Text] [Related]  

  • 10. Argentine hemorrhagic fever.
    Weissenbacher MC; Laguens RP; Coto CE
    Curr Top Microbiol Immunol; 1987; 134():79-116. PubMed ID: 3034513
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevalence of hepatitis C antibodies in plasma donors for the treatment of Argentine hemorrhagic fever].
    Saavedra MC; Briggiler AM; Enría D; Riera L; Ambrosio AM
    Medicina (B Aires); 1997; 57(3):287-93. PubMed ID: 9640761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII: C and factor VIII R: Ag in Argentine hemorrhagic fever.
    Molinas FC; Maiztegui JI
    Thromb Haemost; 1981 Aug; 46(2):525-7. PubMed ID: 6795740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a platelet protein kinase that phosphorylates fibrinogen and histone in Argentine hemorrhagic fever.
    Lerer GD; Saavedra MC; Falcoff R; Maiztegui JI; Molinas FC
    Acta Physiol Pharmacol Ther Latinoam; 1991; 41(4):377-86. PubMed ID: 1726921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group.
    Maiztegui JI; McKee KT; Barrera Oro JG; Harrison LH; Gibbs PH; Feuillade MR; Enria DA; Briggiler AM; Levis SC; Ambrosio AM; Halsey NA; Peters CJ
    J Infect Dis; 1998 Feb; 177(2):277-83. PubMed ID: 9466512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of endogenous interferon and high levels of 2'-5' oligoadenylate synthetase in leukocytes from patients with Argentine hemorrhagic fever.
    Ferbus D; Saavedra MC; Levis S; Maiztegui J; Falcoff R
    J Infect Dis; 1988 May; 157(5):1061-4. PubMed ID: 3361147
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever.
    Levis SC; Saavedra MC; Ceccoli C; Feuillade MR; Enria DA; Maiztegui JI; Falcoff R
    J Interferon Res; 1985; 5(3):383-9. PubMed ID: 4056485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Late neurological complications of Argentine hemorrhagic fever].
    Melcon MO; Herskovits E
    Medicina (B Aires); 1981; 41(2):137-45. PubMed ID: 7278612
    [No Abstract]   [Full Text] [Related]  

  • 18. Argentine hemorrhagic fever: a biologic marker.
    Avila MM; Galassi NV; Weissenbacher MC
    Intervirology; 1981; 15(2):97-102. PubMed ID: 6271705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of monkeys against Machupo virus by the passive administration of Bolivian haemorrhagic fever immunoglobulin (human origin).
    Eddy GA; Wagner FS; Scott SK; Mahlandt BJ
    Bull World Health Organ; 1975; 52(4-6):723-7. PubMed ID: 182406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy.
    Gowen BB; Westover JB; Sefing EJ; Van Wettere AJ; Bailey KW; Wandersee L; Komeno T; Furuta Y
    Antiviral Res; 2017 Sep; 145():131-135. PubMed ID: 28780425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.